Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 12, 2018
LMU Munich: platelet inhibition novel aspects on platelet inhibition and functionLisa Gross, Dirk Sibbing, Christian Schulz, et al.
Journal of the American College of Cardiology|June 12, 2012
Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudyDirk Sibbing, Isabell Bernlochner, Stefanie Schulz, et al.
Thrombosis and Haemostasis|May 6, 2006
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsivenessNicolas von Beckerath, Gisela Pogatsa-Murray, Anna Wieczorek, et al.
American Journal of Clinical Pathology|October 23, 2009
Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube systemSiegmund Braun, Nicolas von Beckerath, Julia Ellert, et al.
European Heart Journal|August 30, 2020
Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEmanuele Barbato, Julinda Mehilli, Dirk Sibbing, et al.
JACC. Advances|May 30, 2025
Advanced Subclinical Atherosclerosis and Low-Dose Aspirin: Guideline-Based Extension Into Asymptomatic Chronic Coronary SyndromesMichael J Blaha, Francesca Santilli, Dirk Sibbing, et al.
American Heart Journal|September 10, 2010
Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular eventsKlaus A Tiroch, Dirk Sibbing, Werner Koch, et al.
Thrombosis and Haemostasis|October 28, 2010
Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patientsJuliane Jaitner, Julia Stegherr, Tanja Morath, et al.
European Heart Journal|February 3, 2007
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 daysNicolas von Beckerath, Adnan Kastrati, Anna Wieczorek, et al.
Annals of Neurology|January 31, 2003
The promoter region of the Menkes gene ATP7A is not altered in focal or generalized dystoniaDirk Sibbing, Iris Trender-Gerhardt, Nick W Wood, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 12, 2018
LMU Munich: platelet inhibition novel aspects on platelet inhibition and functionLisa Gross, Dirk Sibbing, Christian Schulz, et al.
Journal of the American College of Cardiology|June 12, 2012
Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudyDirk Sibbing, Isabell Bernlochner, Stefanie Schulz, et al.
Thrombosis and Haemostasis|May 6, 2006
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsivenessNicolas von Beckerath, Gisela Pogatsa-Murray, Anna Wieczorek, et al.
American Journal of Clinical Pathology|October 23, 2009
Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube systemSiegmund Braun, Nicolas von Beckerath, Julia Ellert, et al.
European Heart Journal|August 30, 2020
Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEmanuele Barbato, Julinda Mehilli, Dirk Sibbing, et al.
JACC. Advances|May 30, 2025
Advanced Subclinical Atherosclerosis and Low-Dose Aspirin: Guideline-Based Extension Into Asymptomatic Chronic Coronary SyndromesMichael J Blaha, Francesca Santilli, Dirk Sibbing, et al.
American Heart Journal|September 10, 2010
Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular eventsKlaus A Tiroch, Dirk Sibbing, Werner Koch, et al.
Thrombosis and Haemostasis|October 28, 2010
Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patientsJuliane Jaitner, Julia Stegherr, Tanja Morath, et al.
European Heart Journal|February 3, 2007
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 daysNicolas von Beckerath, Adnan Kastrati, Anna Wieczorek, et al.
Annals of Neurology|January 31, 2003
The promoter region of the Menkes gene ATP7A is not altered in focal or generalized dystoniaDirk Sibbing, Iris Trender-Gerhardt, Nick W Wood, et al.
Pageof 20